Day: July 9, 2020

Bonjour,Vous trouverez ci-après le communiqué de presse diffusé ce jour.Bien cordialement,Florence LièvreGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________Contact presse :Florence LièvreTel. : +33 1 47 54 50 71E-mail : florence.lievre@capgemini.comWorld Wealth Report 2020 : pour la première fois en huit ans, la croissance de la richesse des particuliers fortunés est plus importante en Amérique du Nord qu’en Asie-Pacifique, dans un contexte d’incertitude lié à la crise COVID-19Les particuliers fortunés s’intéressent aux investissements durables, regardent de près les honoraires de leur gestionnaire de patrimoine et sont à la recherche d’expériences hyper personnalisées.Paris, le 9 juillet 2020 – Le World Wealth Report 2020 de...

PALO ALTO, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Tesla will post its financial results for the second quarter of 2020 after market close on Wednesday, July 22, 2020. At that time, Tesla will issue a brief advisory containing a link to the Q2 2020 update, which will be available on Tesla’s Investor Relations website. Tesla management will hold a live question and answer webcast that day at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) to discuss the Company’s financial and business results and outlook.What: Date of Tesla Q2 2020 Financial Results and Q&A WebcastWhen: Wednesday, July 22, 2020Time: 2:30 p.m. Pacific Time / 5:30 p.m. Eastern TimeQ2 2020 Update: http://ir.tesla.com  Webcast: http://ir.tesla.com (live and replay)Approximately two hours after the Q&A session, an archived version of the webcast will be available...

REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq:RVMD) today announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Revolution Medicines. In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution Medicines, are expected to be approximately $156.0 million, excluding any exercise of the underwriters’ option...

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Argonaut Gold Inc.(TSX: AR) (the “Company”, “Argonaut Gold” or “Argonaut”) confirms the filing of the Technical Report (see press release dated July 3, 2020) in relation to its Florida Canyon mine in Nevada, USA, pursuant to National Instrument 43-101 of the Canadian Securities Administrators.

VANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) — Standard Uranium Ltd. (TSX.V: STND) (“Standard Uranium” or the “Company”) announces that its board of directors has authorized the payment of a one-time performance incentive bonus (the “Incentive Bonus”) to the President and Chief Executive Officer of the Company, Jon Bey. The Incentive Bonus is intended to compensate Mr. Bey for services provided in connection with the successful listing of the Company on the TSX Venture Exchange (the “Exchange”), and to reflect the below market compensation Mr. Bey agreed to accept during the initial listing and financing process.“The Board of Directors commends Mr. Bey for his substantial efforts over the past two years. His successful guidance of the Company through the Exchange listing process and initial financing rounds has added...

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Skyline Investments Inc. (the “Company” or “Skyline”) (TASE: SKLN) respectfully announces the following:Further to the description in the Company’s Board of Directors Report for 2019 (Reference No. 2020-01-027372) and further to the description in the supplementary immediate report dated April 14, 2020 (Reference No. 2020-01-038355) an amendment to the conditional agreement dated March 10, 2020 (the “Amendment”) for the sale of the Company’s Port McNicoll site (the “Site”), was signed on July 8, 2020 (the “Transaction”). As stipulated in the Amendment, the Buyer will waive its due diligence condition and the sale price of the Site will be CAD $33.5 million of which CAD $1 million will be used to cover legal and sale brokerage fees. In accordance with the Amendment, the Buyer paid the Company...